Skip to content

FP7H2020HORIZONEDF

Institut Pasteur

Country
FRFrance
Defence projects
2
Projects, all programmes
303
As coordinator
148
EU contribution (CORDIS)
EUR 209,264,861
Active
2008 to 2026

Projects

303 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
IpaH functionsRole and natural host targets of Shigella IpaH during infectionFP72011CoordinatorEUR 62,500
GLYCOHITGlycomics by High-throughput Integrated TechnologiesFP72011ParticipantEUR 186,230
GSL in developmentThe role of glycosphingolipids in developmentFP72011CoordinatorEUR 62,500
EVOTAREvolution and Transfer of Antibiotic ResistanceFP72011ParticipantEUR 174,584
DICIGDynamic Interplay between Eukaryotic Chromosomes: Impact on Genome StabilityFP72011CoordinatorEUR 1,497,000
STRONGERStrengthening transdisciplinary research on infectious and emerging diseases in French Guiana: linking fieldwork, benchside and bedsideFP72011CoordinatorEUR 3,726,156
EUROWESTNILEEuropean West Nile collaborative research projectFP72011ParticipantEUR 229,177
PREDEMICSPreparedness, Prediction and Prevention of Emerging Zoonotic Viruses with Pandemic Potential using Multidisciplinary ApproachesFP72011CoordinatorEUR 3,201,554
ADITECAdvanced Immunization TechnologiesFP72011ParticipantEUR 920,000
HBPHuman Brain ProjectFP72011ParticipantEUR 80,892
HK97 maturationStructural studies of HK97 bacteriophage assembly and maturationFP72011CoordinatorEUR 232,677
MM4TBMore Medicines for TuberculosisFP72011ParticipantEUR 492,920
FAPULFolding and assembly of the outer membrane component PulD of the type II secretion pathway of Klebsiella oxytocaFP72011CoordinatorEUR 185,748
MODHEPSystems biology of liver cancer: an integrative genomic-epigenomic approachFP72011ParticipantEUR 800,000
ANTIFLUInnovative anti-influenza drugs excluding viral escapeFP72011ParticipantEUR 38,901
ANTIGONEANTIcipating the Global Onset of Novel EpidemicsFP72011ParticipantEUR 624,000
GM_NCD_IN_COReinforcing IPT capacities in Genomic Medicine, Non Communicable Diseases Investigation and international cooperationFP72011ParticipantEUR 149,800
RUPTEFFECTSRevealing the mechanism of host membrane rupture by invasive pathogens and its role in triggering the immune responseFP72011CoordinatorEUR 1,488,512
LYMPHOCYTECONTACTSRegulation and outcome of immune cell interactions in vivoFP72011CoordinatorEUR 1,485,512
EDENEXTBiology and control of vector-borne infections in EuropeFP72011ParticipantEUR 417,200

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.